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1909-261 There are Gender-Related Differences in Vessel
Size, but not In Target Lesion Plaque
Composition: A Pre-Intervention Intravascular
Ultrasound Study
Two year cardiac mortality was lower in pts with MV (5%) than in those
without MV (30%, P < 0.01). These data indicate that demonstration of sig-
nificant MV with DSE has important prognostic value in pts with LVD which
is independent of resting ejection fraction,
Females Males p
Reference EEM area (mm2) 17.8 ± 5.6 199 ± 7.0 0.0006
Reference lumen area (mm 2) 89 ± 3.2 98 ± 4.0 0.013
Reference P + M area (mm2) 6.8± 116 7.2 ± 14.3 NS
Reference % CSN 48.5 ± 129 50.1 ± 12.1 NS
Lesion EEM area (mm2) 176 ± 5.8 20.1 ± 5.5 0.0098
Lesion lumen area (mm2 ) 1.8 ± 0.8 1.9 ± 1.1 NS
Lesion P + M area (mm2) 15.8 ± 5.7 17.7 ± 6.9 00097
Lesion % CSN 88.8 ± 62 89.7 ± 63 NS
Lesion/Reference EEM area 104 ± 0.24 1.00 ± 0.21 NS
Lesion/Reference P + M area 2.19 ± 1.14 2.02±213 NS
Gary S. Mintz, Jeffrey J. Popma, Augusto D. Pichard, Kenneth M. Kent, Lowell
F. Satler, Carol L. Walsh, Christine J. Ditrano, Karen Knaell, Donna Hunn, Martin
B. Leon. Washington Hospital Center. Washington, DC
Pre-intervention intravascular ultrasound imaging was used to assess the
presence of gender-related differences in 627 focal, significant (quantitative
angiographic diameter stenosis = 67 ± 16%), de novo, native vessel lesions
in 465 males and 162 females (ages 60 ± 12 yrs). Lesion site external elastic
membrane (EEM),lumen, and plaque + media (P + M) cross-sectional areas
and % cross-sectional narrowing (%CSN = P + M/EEM were compared to
a proximal reference site (most normal looking cross-section within 10 mm
of the lesion, but before major side branches).
There were no gender-related differences in lesion eccentricity (maxi-
mum/minimum P + M thickness = 2,8 ± 2.6 vs 3.1 ± 2.6), lesion or ref-
erence site plaque composition (frequency of fibrocalcific plaque elements),
arc of calcium (104 ± 117° vs 105 ± 106°), or calcium distribution (superficial
vs deep). We Conclude: Pre-intervention intravascular ultrasound imaging
failed to detect any qualitative differences in de novo target lesion plaque
composition or distribution in females compared to males. Arteries were
smaller in females (smaller reference lumen and EEM areas and smaller le-
sion site EEM areas). However, the extent of compensatory arterial remod-
eling was similar (no difference in reference site and lesion site %CSN or in
lesion/reference EEM area). The reduced target lesion plaque cross-sectional
area in females can be explained entirely by the the smaller arterial size (no
difference in lesion/reference P + M area).
Echo Echo SPECT SPECT
V NV V NV
PET-V 31 20 45 3
PET-NV 17 18 33 1
Echo-V 42 1
Echo-NV 35 3
Value of Dobutamine-Echocardiogram in
Predicting Functional Recovery of Hypokinetic or
Akinetic Myocardium After Coronary
Revascularlsation
Rudolf Strasser, Albrecht Elsasser, Klaus D. MOiler, Hassan Bahavar,
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Germany
Regional myocardial akinesialhypokinesia at rest has been reported to
represent either nonviable (NV) or viable IV) myocardium. On the basis
of fixed threshold values, FDG-PET (PET). Sestamibi-SPECT (SPECT) and
Dobutamine-echocardiography (Echo) have been used to assess myocar-
dial viability. We investigated the concordance between these methods in
dysfunctional myocardium. 19 non-diabetic patients (age 60 ± 10 years)
with CAD and resting echocardiographic regional contractile dysfunction in
at least 2 myocardial segments (16 segment model) were studied. Within
1 month of coronary angiography, PET (glucose-insulin clamp) SPECT and
ECho (5--10 ",g/kg/min) were performed. Normal myocardium was defined in
each patient as a normokinetic segment supplied by an angiographically nor-
mal artery, and with average segmental peak Sestamibi uptake. The follow-
ing threshold values were used: PET-V was defined by FDG >70% of peak.
Improvement of 1 in wall motion score was defined as Echo-V Sestamibi
uptake >50% of peak was defined as SPECT-V and <35% as SPECT-NV
Resting echocardiography identified 86 dysfunctional segments.
In 40 patients with stable coronary artery disease, we prospectively tried
to predict the recovery of left ventricular regional wall motion abnormali-
ties. Echocardiographic examination was done before and 3 months after
coronary artery bypass surgery (CABG), 16 distinct regions were judged as
normal, mildly hypokinetic, severely hypokinetic or akinetic without knowing
the results of CABG. Before CABG, dobutamine echocardiography (5 to 10
",/kg bw/min iv) was done. Regions with improvement of wall motion during
dobutamine infusion (Dob+) were expected to recover after CABG.
Resu/ts: Of 412 regions with wall motion abnormalities and angiographi-
cally proven successful revascularisation 315 were Dob+, 263 showed im-
proved wall motion after CABG, 52 do not. Out of 97 regions without im-
provement after dobutamine, only 6 showed improved wall motion after
CABG. Sensitivity of Dob+ is 97.8%, specificity 63.6%, positive predictive
value 83.5%, negative predictive value 93.8%,
Conclusion: Dobutamine Echocardiography is useful to predict improve-
ment of wall motion after CABG in hypokinetic or akinetic regions and differ-
entiates viable (hibernating) myocardium from scar tissue areas.
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Comparison of FDG-PET, Sestamibi SPECT and
Dobutamine-Echocardiography in Dysfunctional
Myocardium
Klaus Kofoed, Steen Carstensen, Henning Kelbooek, Birger Hesse 1, Stig Hauns".
The Heart Center, Rigshospitalet University of Copenhagen, Denmark; 1 Department of
Nuclear Medicine, Rigshospitalet University of Copenhagen. Denmark
1909-291
Prognostic Value of Dobutamine Stress
Echocardiography in Patients with Left
Ventricular Dysfunction
Jason T. Tauke, Thomas 0, Kong, Renata S, Alessandrini, Gil M. Vardi, Michele
A. Parker, Robert O. Bonow, Farooq A. Chaudhry, Northwestern University Medical
School, Chicago, IL
The prognostic value of demonstrable myocardial viability (MV) was evalu-
ated in 57 consecutive pts (mean age 65 ± 11.74% male) with left ventric-
ular dysfunction (LVD-ejection fraction ::::40%) who underwent dobutamine
stress echocardiography (DSE). Myocardial segments were scored at base-
line and low dose dobutamine (2.5--20 mcg/kg/min) using a 16 segment
model. Significant MV was defined as an improvement of baseline wall mo-
tion score in ~4 segments with low dose dobutamine. Long term follow
up was obtained in all pts (mean 13.5 months). Significant MV was demon-
strated in 37 pts (65%). There was no difference in resting ejection fraction
between pts with or without MV (27% vs 25%, P = 0.48). Fourteen pts (25%)
had cardiac events (9 cardiac deaths, 5 Mil. Actuarial event free survival was
strongly related to the presence of MV as shown below:
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Conclusion: The concordance between regional FDG uptake, dobutamine-
response and Sestamibi uptake in dysfunctional myocardium is moderate to
poor, despite the use of generally applied threshold values, These findings
suggest that dysfunctional. but "viable" myocardium may represent several
pathophysiological entities.
Transesophageal Dobutamine Stress
Echocardiography for Detection of Coronary
Artery Disease in Women Presenting with Chest
Pain: Comparison with Other Standard Tests
Joy M. Laurienzo, Richard O. Cannon III, Arshed A. Ouyyumi, Vasken Dilsizian,
Julio A. Panza. NHLBI, Bethesda, MD
Non-invasive identification of coronary artery disease (CAD) in women is hin-
dered by a relatively high incidence of false positive studies. We have shown
that transesophageal dobutamine stress echocardiography(TEDSE) is a use-
ful technique for assessment of CAD in a predominantely male population.
